Pipeline

Original products

Products Clinical indication Region Licensee
Ripasudil hydrochloride hydrate GLANATEC® Glaucoma and ocular hypertension Japan Kowa
Asia
Vietnam
K-321 Fuchs endothelial corneal dystrophy U.S.
K-232 (Ripasudil hydrochloride hydrate/ Brimonidine tartrate) K-232 Glaucoma and ocular hypertension Japan
H-1337 Glaucoma and ocular hypertension U.S. Developed internally

In-licensed products

Products Clinical indication Region Licensee
DW-1001 Ophthalmic treatment agent Japan ROHTO Pharmaceutical
DW-1002 ILM peeling Europe, US and Canada DORC
ILM staining Japan Wakamoto Pharmaceutical
Cataract surgery Japan Wakamoto Pharmaceutical
DW-5LBT Neuropathic pain after shingles US Jointly developed with MEDRx

R&D Projects for new drug discovery

Products Clinical indication Development process Partner
Signal transduction inhibitor developing projects Ophthalmology,Central Nervous System,Cardiovascular System,Respiratory System Fundamental Research Mie Univ. etc.
New device developing projects Glaucoma,Corneal disorders,Retinal diseases Fundamental Research Glaukos

Pipeline developed by subsidiary JIT

Products Clinical indication Region Development process Partner (Origin)
Treatment for
retinopathy of prematurity
Retinopathy of prematurity Japan Non-clinical studies JIT(Tokyo University of Agriculture and Technology)